Study wearable and symptom monitoring during respiratory virus challenges
Part of Infections, Lungs & breathing clinical trials.
This observational study looks for digital health patterns during studies where people are intentionally exposed to a respiratory virus. If you join a respiratory virus challenge at NIH, you may help researchers discover better ways to monitor and understand illness using wearable devices and shared health data.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can give informed consent (agree to participate after understanding the study).
- You are currently enrolled, recently enrolled, or planning to join a respiratory virus challenge study at the NIH Clinical Center.
- You are willing to wear monitoring devices as the study team instructs.
- You are willing to follow monitoring and check-in activities as instructed.
- You agree to store your monitoring data for the study.
- You agree that certain health data (like vital signs, virus shedding, lung function/spirometry, and symptoms) can be shared with researchers at NIH, the University of Washington, and the University of Toronto.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects samples from people who have or might have a cold/respiratory virus, then stores them for future research. It may help researchers better understand respiratory germs and develop better treatments.
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
This study looks at how your immune system fights off flu or COVID-19. If you have a current or recent infection, or if you've been vaccinated in the past year, you may be able to join.
This study looks at flu-like symptoms and other respiratory infections in adults in Lusaka, Zambia. It aims to understand how these infections affect people with and without HIV, and may help improve care.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.